NASDAQ
Singular Genomics Systems, Inc. (OMIC) has a free cash flow growth of -9.73% as of Friday, May 29, 2026. This represents a 1170.89% decrease compared to its 12-month average of 0.91%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.